
Albert Mark Navarro
Examiner (ID: 439, Phone: (571)272-0861 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1621, 2899, 1817 |
| Total Applications | 2079 |
| Issued Applications | 1540 |
| Pending Applications | 155 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16230551
[patent_doc_number] => 10738089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Use of a polypeptide for effecting immune signalling and/or affecting intestinal barrier function and/or modulating metabolic status
[patent_app_type] => utility
[patent_app_number] => 15/571175
[patent_app_country] => US
[patent_app_date] => 2016-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11826
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15571175
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/571175 | Use of a polypeptide for effecting immune signalling and/or affecting intestinal barrier function and/or modulating metabolic status | May 3, 2016 | Issued |
Array
(
[id] => 11642459
[patent_doc_number] => 09663817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Methods and means for characterizing antibiotic resistance in microorganisms'
[patent_app_type] => utility
[patent_app_number] => 15/132565
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7344
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15132565
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/132565 | Methods and means for characterizing antibiotic resistance in microorganisms | Apr 18, 2016 | Issued |
Array
(
[id] => 12621639
[patent_doc_number] => 20180099043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => METHODS TO IMPROVE INDUCTION OF IGA ANTIBODIES BY VACCINES
[patent_app_type] => utility
[patent_app_number] => 15/566884
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566884
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566884 | Methods to improve induction of IgA antibodies by vaccines | Apr 14, 2016 | Issued |
Array
(
[id] => 16063419
[patent_doc_number] => 10690651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Small molecule metabolites for the diagnosis of bacterial vaginosis and assessment of disease risk
[patent_app_type] => utility
[patent_app_number] => 15/566240
[patent_app_country] => US
[patent_app_date] => 2016-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19868
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566240
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566240 | Small molecule metabolites for the diagnosis of bacterial vaginosis and assessment of disease risk | Apr 12, 2016 | Issued |
Array
(
[id] => 11016817
[patent_doc_number] => 20160213770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'Methods of using Salmonella enterica presenting C. Jejuni N-glycan or derivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 15/094537
[patent_app_country] => US
[patent_app_date] => 2016-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8488
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15094537
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/094537 | Methods of using Salmonella enterica presenting C. jejuni N-glycan or derivatives thereof | Apr 7, 2016 | Issued |
Array
(
[id] => 13139841
[patent_doc_number] => 10087241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Polypeptdes, cells, and methods for biofilm therapy and detection
[patent_app_type] => utility
[patent_app_number] => 15/080254
[patent_app_country] => US
[patent_app_date] => 2016-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 10850
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/080254 | Polypeptdes, cells, and methods for biofilm therapy and detection | Mar 23, 2016 | Issued |
Array
(
[id] => 15448195
[patent_doc_number] => 10548325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Strain of
[patent_app_type] => utility
[patent_app_number] => 15/561481
[patent_app_country] => US
[patent_app_date] => 2016-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11051
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561481
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/561481 | Strain of | Mar 22, 2016 | Issued |
Array
(
[id] => 12580473
[patent_doc_number] => 20180085320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
[patent_app_type] => utility
[patent_app_number] => 15/558636
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558636 | Modulating antibacterial immunity via bacterial membrane-coated nanoparticles | Mar 17, 2016 | Issued |
Array
(
[id] => 10987430
[patent_doc_number] => 20160184370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'Compositions and Methods'
[patent_app_type] => utility
[patent_app_number] => 15/068438
[patent_app_country] => US
[patent_app_date] => 2016-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 68822
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15068438
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/068438 | Compositions and methods | Mar 10, 2016 | Issued |
Array
(
[id] => 13013893
[patent_doc_number] => 10030054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Campylobacter immunogenic compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/065979
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10709
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15065979
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/065979 | Campylobacter immunogenic compositions and uses thereof | Mar 9, 2016 | Issued |
Array
(
[id] => 13968093
[patent_doc_number] => 10213378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Single dose non-adjuvanted cutaneous tetanus vaccine and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/066961
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 5207
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15066961
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/066961 | Single dose non-adjuvanted cutaneous tetanus vaccine and uses thereof | Mar 9, 2016 | Issued |
Array
(
[id] => 12139474
[patent_doc_number] => 20180017557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'Antibodies to the Surface of Toxoplasma Gondii Oocysts and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/548062
[patent_app_country] => US
[patent_app_date] => 2016-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19591
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548062
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548062 | Antibodies to the surface of | Mar 7, 2016 | Issued |
Array
(
[id] => 11351629
[patent_doc_number] => 20160370369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'ULTRAPURIFIED DsbA AND DsbC AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/061943
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 48861
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061943
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/061943 | Ultrapurified DsbA and DsbC and methods of making and using the same | Mar 3, 2016 | Issued |
Array
(
[id] => 11123431
[patent_doc_number] => 20160320404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'SERUM ANTIBODY ASSAY FOR DETERMINING PROTECTION FROM MALARIA, AND PRE-ERYTHROCYTIC SUBUNIT VACCINES'
[patent_app_type] => utility
[patent_app_number] => 15/060959
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22311
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15060959
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/060959 | SERUM ANTIBODY ASSAY FOR DETERMINING PROTECTION FROM MALARIA, AND PRE-ERYTHROCYTIC SUBUNIT VACCINES | Mar 3, 2016 | Abandoned |
Array
(
[id] => 10981683
[patent_doc_number] => 20160178626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'HUMAN STREPTOCOCCUS PNEUMONIAE ANTIBODIES AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 15/058814
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27933
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15058814
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/058814 | Human | Mar 1, 2016 | Issued |
Array
(
[id] => 10987482
[patent_doc_number] => 20160184427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/054801
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9945
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054801
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/054801 | QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF | Feb 25, 2016 | Abandoned |
Array
(
[id] => 11872448
[patent_doc_number] => 09744197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Process and composition for manufacture of a microbial-based product'
[patent_app_type] => utility
[patent_app_number] => 15/050178
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26670
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050178
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050178 | Process and composition for manufacture of a microbial-based product | Feb 21, 2016 | Issued |
Array
(
[id] => 11106244
[patent_doc_number] => 20160303214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'PROCESS FOR DETERGENT-FREE PRODUCTION OF OUTER MEMBRANE VESICLES OF A GRAM-NEGATIVE BACTERIUM'
[patent_app_type] => utility
[patent_app_number] => 15/045424
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11064
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15045424
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/045424 | Process for detergent-free production of outer membrane vesicles of a gram-negative bacterium | Feb 16, 2016 | Issued |
Array
(
[id] => 12144826
[patent_doc_number] => 09879067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-30
[patent_title] => 'Stabilized liquid anti-RSV antibody formulations'
[patent_app_type] => utility
[patent_app_number] => 15/041295
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 30201
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15041295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/041295 | Stabilized liquid anti-RSV antibody formulations | Feb 10, 2016 | Issued |
Array
(
[id] => 13383621
[patent_doc_number] => 20180243352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => LACTIC ACID BACTERIA, NATURAL IMMUNOACTIVATOR AND INFECTION PREVENTATIVE/THERAPEUTIC DERIVED FROM SAID LACTIC ACID BACTERIA, AND FOOD/BEVERAGE
[patent_app_type] => utility
[patent_app_number] => 15/547865
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547865
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547865 | Lactic acid bacteria, natural immunoactivator and infection preventative/therapeutic derived from said lactic acid bacteria, and food/beverage | Feb 3, 2016 | Issued |